Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1

Cancer Research

Volumn 56, Issue 24, 1996, Pages 5684-5691

  Hsu, Stephanie C ^a   Volpert, Olga V ^a   Steck, Peter A ^b   Mikkelsen, Tom ^c   Polverini, Peter J ^d   Rao, Sambasiva ^a   Chou, Pauline ^e   Bouck, Noël P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHROMOSOME 10; GENE INDUCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ANIMALS; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 10; ENDOTHELIAL GROWTH FACTORS; GLIOBLASTOMA; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; RATS; THROMBOSPONDINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029754648     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Folkman, J Tumor Angiogenesis In: J Mendelsohn, P. M Howley, M A Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp 206-232 Philadelphia, W B, Saunders, 1995.
2. Bouck, N , Stellmach, V , and Hsu, S How tumors become angiogenic. Adv. Cancer Res, 69: 135-174, 1996
3. Hanahan, D. and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86 353-364, 1996
4. Plate, K. H., and Risau, W. Angiogenesis in malignant gliomas. Glia, 15: 339-347, 1995
5. Kim, K J., Li, B , Winer, J., Armanini, M., Gillett, N , Phillips, H. S , and Ferrara, N Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature (Lond.), 362: 841-844, 1993.
6. Saleh, M , Stacker, S. A , and Wilks, A F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence Cancer Res., 56: 393-401, 1996.
7. Millauer, B, Shawver, L K., Plate, K H, Risau, W , and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature (Lond.), 367: 576-579, 1994.
8. Rak, J., Mitsubishi, Y , Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R S Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
9. Dameron, K. M, Volpert, O V, Tainsky, M. A, and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 Science (Washington DC), 265: 1582-1584, 1994.
10. Dameron, K. M.. Volpert, O. V., Tainsky, M. A., and Bouck, N. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symp. Quant. Biol , 59: 483-489, 1994.
11. Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J. J., Chen, H., Mosher, D. F., and Bouck, N. Inhibition of angiogenesis by thrombospondin-2. Biochem. Biophys. Res. Commun., 217 326-332, 1995.
12. Good, D. J., Polverini, P. J., Rastinejad, F , Le Beau, M. M., Lemons, R. S., Frazier, W. A , and Bouck, N P A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of chrombospondin. Proc Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
13. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol., 122. 497-511, 1993.
14. Weinstat-Saslow, D. L., Zabrenetzky, V. S., VanHoutte, K, Frazier, W. A, Roberts, D. D., and Steeg, P. S Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res., 54: 6504-6511, 1994.
15. Sheibani, N., and Frazier, W. A. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 6788-6792, 1995.
16. Louis, D N , and Gusella, J. F. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet, 11: 412-415, 1995.
17. Westermark, B., and Nister, M Molecular genetics of human glioma. Curr. Opin Oncol., 7: 220-225, 1995.
18. Leon, S P., Zhu, J., and Black, P. M Genetic aberrations in human brain tumors. Neurosurgery, 34: 708-722, 1994.
19. Pershouse, M. A , Stubblefield, E., Hadi, A., Killary, A. M., Yung, W. K., and Steck, P A. Analysis of the functional role of chromosome 10 loss in human glioblastomas Cancer Res., 53. 5043-5050, 1993.
20. Steck, P. A., Ligon, A. H., Cheong, P., Yung, W. K., and Pershouse, M A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer, 12. 255-261, 1995.
21. Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H. J., de Tribolet, N., and Cavenee, W. K Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet., 8: 171-176, 1994.
22. Prater, C A , Plotkin, J., Jaye, D., and Frazier, W A. The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J. Cell Biol, 112: 1031-1040, 1991
23. Chan, T. S , Creagan, R. P., and Reardon, M P. Adenosine kinase as a new selective marker in somatic cell genetics: isolation of adenosine kinase-deficient mouse cell lines and human-mouse hybrid cell lines containing adenosine kinase Somatic Cell Genet, 4: 1-12, 1978
24. Polverini, P. J., Bouck, N. P., and Rastinejad, F. Assay and purification of naturally occurring inhibitor of angiogenesis Methods Enzymol, 198: 440-450, 1991
25. Abe, M , Harpel, J G., Metz, C. N , Nunes, I., Loskutoff, D. J., and Rifkin, D B. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem, 216: 276-284, 1994.
26. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T M., Krutzsch, H C., Roberts, D. D., and Murphy-Ullrich, S. E Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem., 270: 7304-7310, 1995.
27. Yamada, N., Kato, M., Yamashita, H., Nister, M., Miyazono, K, Heldin, C. H., and Funa, K Enhanced expression of transforming growth factor-β and its type-I and type-II receptors in human glioblastoma. Int J. Cancer, 62: 386-392, 1995.
28. Jennings, M. T., Maciunas, R. J., Carver, R., Bascom, C. C., Juneau, P., Misulis, K , and Moses, H. L. TGF β1 and TGF β2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis Int. J. Cancer, 49: 129-139, 1991.
29. Merzak, A , McCrea, S., Koocheckpour, S , and Pilkington, G. J. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor β1. Br. J. Cancer, 70: 199-203, 1994.
30. Asch, A. S , Leung, L. L., Shapiro, J , and Nachman, R. L. Human brain glial cells synthesize thrombospondin Proc. Natl. Acad. Sci. USA, 83: 2904-2908, 1986.
31. O'Shea, K. S., Rheinheimer, J. S., and Dixit, V. M. Deposition and role of thrombospondin in the histogenesis of the cerebellar cortex. J. Cell Biol., 110: 1275-1283, 1990
32. Buee, L., Hof, P. R., Roberts, D. D., Delacourte, A , Morrison, J. H., and Fillit, H M. Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease. Am. J. Pathol., 141: 783-788, 1992
33. Rastinejad, F, Polverini, P. J., and Bouck, N P Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345-355, 1989.
34. Gomez-Manzano, C, Fueyo, J , Kyritsis, A P., Steck, P A., Roth, J. A., McDonnell, T. J., Steck, K D , Levin, V. A , and Yung, W. K. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res., 56: 694-699, 1996.
35. Tabuchi, K., Fukuyama, K., Mineta, T., Oh-Uchida, M., and Hori, K. Altered structure and expression of the p53 gene in human neuroepithelial tumors. Neurol Med. Chir., 32: 725-732, 1992.
36. Van Meir, E. G., Kikuchi, T , Tada, M , Li, H., Diserens, A. C., Wojcik, B E , Huang, H. J., Friedmann, T., de Tribolet, N., and Cavenee, W K Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res, 54: 649-652, 1994.
37. Asai, A., Miyagi, Y., Sugiyama, A, Gamanuma, M, Hong, S. H., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., and Kuchino, Y Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J. Neuro-Oncol., 19: 259-268, 1994.
38. Kieser, A, Weich, H A., Brandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9. 963-969, 1994.
39. Plate, K H, Breier, G, Weich, H. A., Mennel, H D, and Risau, W. Vascular endothelial growth factor and glioma angiogenesis coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J Cancer, 59: 520-529, 1994.